{"count": 20, "results": [{"_id": "33383013", "pmid": 33383013, "title": "Effect of Losartan or Atenolol on Children and Young Adults With Bicuspid Aortic Valve and Dilated Aorta.", "journal": "Am J Cardiol", "authors": ["Flyer JN", "Sleeper LA", "Colan SD", "Singh MN", "Lacro RV"], "date": "2021-04-01T00:00:00Z", "doi": "10.1016/j.amjcard.2020.12.050", "meta_date_publication": "2021 Apr 1", "meta_volume": "144", "meta_issue": "", "meta_pages": "111-117", "score": 50266.57, "text_hl": "Effect of @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@Losartan@@@ or @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ on Children and Young Adults With @DISEASE_Bicuspid_Aortic_Valve_Disease @DISEASE_MESH:D000082882 @@@Bicuspid Aortic Valve@@@ and @<m>DISEASE_Cardiomyopathy_Dilated</m> @DISEASE_MESH:D002311 @@@Dilated Aorta@@@.", "citations": {"NLM": "Flyer JN, Sleeper LA, Colan SD, Singh MN, Lacro RV. Effect of Losartan or Atenolol on Children and Young Adults With Bicuspid Aortic Valve and Dilated Aorta. Am J Cardiol. 2021 Apr 1;144():111-117. PMID: 33383013", "BibTeX": "@article{33383013, title={Effect of Losartan or Atenolol on Children and Young Adults With Bicuspid Aortic Valve and Dilated Aorta.}, author={Flyer JN and Sleeper LA and Colan SD and Singh MN and Lacro RV}, journal={Am J Cardiol}, volume={144}, pages={111-117}}"}}, {"_id": "2285633", "pmid": 2285633, "title": "Atenolol in dilated cardiomyopathy: a clinical instrumental study.", "journal": "Cardiovasc Drugs Ther", "authors": ["Mattioli AV", "Modena MG", "Fantini G", "Mattioli G"], "date": "1990-04-01T00:00:00Z", "doi": "10.1007/BF01857761", "meta_date_publication": "1990 Apr", "meta_volume": "4", "meta_issue": "2", "meta_pages": "505-7", "score": 50087.758, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ in @<m>DISEASE_Cardiomyopathy_Dilated</m> @DISEASE_MESH:D002311 @@@dilated cardiomyopathy@@@: a clinical instrumental study.", "citations": {"NLM": "Mattioli AV, Modena MG, Fantini G, Mattioli G. Atenolol in dilated cardiomyopathy: a clinical instrumental study. Cardiovasc Drugs Ther. 1990 Apr;4(2):505-7. PMID: 2285633", "BibTeX": "@article{2285633, title={Atenolol in dilated cardiomyopathy: a clinical instrumental study.}, author={Mattioli AV and Modena MG and Fantini G and Mattioli G}, journal={Cardiovasc Drugs Ther}, volume={4}, number={2}, pages={505-7}}"}}, {"_id": "9623012", "pmid": 9623012, "title": "Short-term effects of atenolol in patients with dilated cardiomyopathy.", "journal": "J Med Assoc Thai", "authors": ["Krittayaphong R", "Mahanonda N", "Kangkagate C", "Phankingthongkum R", "Chaithiraphan S"], "date": "1998-03-01T00:00:00Z", "meta_date_publication": "1998 Mar", "meta_volume": "81", "meta_issue": "3", "meta_pages": "201-7", "score": 50081.99, "text_hl": "Short-term effects of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Cardiomyopathy_Dilated</m> @DISEASE_MESH:D002311 @@@dilated cardiomyopathy@@@.", "citations": {"NLM": "Krittayaphong R, Mahanonda N, Kangkagate C, Phankingthongkum R, Chaithiraphan S. Short-term effects of atenolol in patients with dilated cardiomyopathy. J Med Assoc Thai. 1998 Mar;81(3):201-7. PMID: 9623012", "BibTeX": "@article{9623012, title={Short-term effects of atenolol in patients with dilated cardiomyopathy.}, author={Krittayaphong R and Mahanonda N and Kangkagate C and Phankingthongkum R and Chaithiraphan S}, journal={J Med Assoc Thai}, volume={81}, number={3}, pages={201-7}}"}}, {"_id": "15941137", "pmid": 15941137, "title": "[Influence of therapy with atenolol on lethality of patients with chronic heart failure].", "journal": "Klin Med (Mosk)", "authors": ["Syrkina EA", "Vyshinskaia ID", "Aleksinskaia TV", "Syrkin AL"], "date": "2005-01-01T00:00:00Z", "meta_date_publication": "2005", "meta_volume": "83", "meta_issue": "4", "meta_pages": "23-8", "score": 50070.58, "text_hl": "The paper demonstrates that the hydrophilic beta-adrenoblocker (BAB) @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ is effective in @SPECIES_9606 @@@patients@@@ with III-IV functional class chronic @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@heart failure@@@ (@DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@CHF@@@), associated with postinfarction cardiosclerosis (PIC) and @<m>DISEASE_Cardiomyopathy_Dilated</m> @DISEASE_MESH:D002311 @@@dilatational cardiomyopathy@@@ (@<m>DISEASE_Cardiomyopathy_Dilated</m> @DISEASE_MESH:D002311 @@@DC@@@). ", "citations": {"NLM": "Syrkina EA, Vyshinskaia ID, Aleksinskaia TV, Syrkin AL. [Influence of therapy with atenolol on lethality of patients with chronic heart failure]. Klin Med (Mosk). 2005;83(4):23-8. PMID: 15941137", "BibTeX": "@article{15941137, title={[Influence of therapy with atenolol on lethality of patients with chronic heart failure].}, author={Syrkina EA and Vyshinskaia ID and Aleksinskaia TV and Syrkin AL}, journal={Klin Med (Mosk)}, volume={83}, number={4}, pages={23-8}}"}}, {"_id": "30261963", "pmid": 30261963, "title": "Losartan Versus Atenolol for Prevention of Aortic Dilation in Patients With Marfan Syndrome.", "journal": "J Am Coll Cardiol", "authors": ["Teixido-Tura G", "Forteza A", "Rodríguez-Palomares J", "González Mirelis J", "Gutiérrez L", "Sánchez V", "Ibáñez B", "García-Dorado D", "Evangelista A"], "date": "2018-10-02T00:00:00Z", "doi": "10.1016/j.jacc.2018.07.052", "meta_date_publication": "2018 Oct 2", "meta_volume": "72", "meta_issue": "14", "meta_pages": "1613-1618", "score": 50068.42, "text_hl": "@CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@Losartan@@@ Versus @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ for Prevention of @<m>DISEASE_Cardiomyopathy_Dilated</m> @DISEASE_MESH:D002311 @@@Aortic Dilation@@@ in @SPECIES_9606 @@@Patients@@@ With @DISEASE_Marfan_Syndrome @DISEASE_MESH:D008382 @@@Marfan Syndrome@@@.", "citations": {"NLM": "Teixido-Tura G, Forteza A, Rodríguez-Palomares J, González Mirelis J, Gutiérrez L, Sánchez V, Ibáñez B, García-Dorado D, Evangelista A. Losartan Versus Atenolol for Prevention of Aortic Dilation in Patients With Marfan Syndrome. J Am Coll Cardiol. 2018 Oct 2;72(14):1613-1618. PMID: 30261963", "BibTeX": "@article{30261963, title={Losartan Versus Atenolol for Prevention of Aortic Dilation in Patients With Marfan Syndrome.}, author={Teixido-Tura G and Forteza A and Rodríguez-Palomares J and González Mirelis J and Gutiérrez L and Sánchez V and Ibáñez B and García-Dorado D and Evangelista A}, journal={J Am Coll Cardiol}, volume={72}, number={14}, pages={1613-1618}}"}}, {"_id": "21561700", "pmid": 21561700, "title": "[Study of the efficacy and safety of losartan versus atenolol for aortic dilation in patients with Marfan syndrome].", "journal": "Rev Esp Cardiol", "authors": ["Forteza A", "Evangelista A", "Sánchez V", "Teixidó G", "García D", "Sanz P", "Gutiérrez L", "Centeno J", "Rodríguez-Palomares J", "Cortina J", "García-Dorado D"], "date": "2011-06-01T00:00:00Z", "doi": "10.1016/j.recesp.2011.02.009", "meta_date_publication": "2011 Jun", "meta_volume": "64", "meta_issue": "6", "meta_pages": "492-8", "score": 50064.945, "text_hl": "[Study of the efficacy and safety of @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ versus @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ for @<m>DISEASE_Cardiomyopathy_Dilated</m> @DISEASE_MESH:D002311 @@@aortic dilation@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Marfan_Syndrome @DISEASE_MESH:D008382 @@@Marfan syndrome@@@].", "citations": {"NLM": "Forteza A, Evangelista A, Sánchez V, Teixidó G, García D, Sanz P, Gutiérrez L, Centeno J, Rodríguez-Palomares J, Cortina J, García-Dorado D. [Study of the efficacy and safety of losartan versus atenolol for aortic dilation in patients with Marfan syndrome]. Rev Esp Cardiol. 2011 Jun;64(6):492-8. PMID: 21561700", "BibTeX": "@article{21561700, title={[Study of the efficacy and safety of losartan versus atenolol for aortic dilation in patients with Marfan syndrome].}, author={Forteza A and Evangelista A and Sánchez V and Teixidó G and García D and Sanz P and Gutiérrez L and Centeno J and Rodríguez-Palomares J and Cortina J and García-Dorado D}, journal={Rev Esp Cardiol}, volume={64}, number={6}, pages={492-8}}"}}, {"_id": "26518245", "pmid": 26518245, "title": "Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial.", "journal": "Eur Heart J", "authors": ["Forteza A", "Evangelista A", "Sánchez V", "Teixidó-Turà G", "Sanz P", "Gutiérrez L", "Gracia T", "Centeno J", "Rodríguez-Palomares J", "Rufilanchas JJ", "Cortina J", "Ferreira-González I", "García-Dorado D"], "date": "2016-03-21T00:00:00Z", "doi": "10.1093/eurheartj/ehv575", "meta_date_publication": "2016 Mar 21", "meta_volume": "37", "meta_issue": "12", "meta_pages": "978-85", "score": 50064.79, "text_hl": "Efficacy of @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ vs. @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ for the prevention of @<m>DISEASE_Cardiomyopathy_Dilated</m> @DISEASE_MESH:D002311 @@@aortic dilation@@@ in @DISEASE_Marfan_Syndrome @DISEASE_MESH:D008382 @@@Marfan syndrome@@@: a randomized clinical trial.", "citations": {"NLM": "Forteza A, Evangelista A, Sánchez V, Teixidó-Turà G, Sanz P, Gutiérrez L, Gracia T, Centeno J, Rodríguez-Palomares J, Rufilanchas JJ, Cortina J, Ferreira-González I, García-Dorado D. Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial. Eur Heart J. 2016 Mar 21;37(12):978-85. PMID: 26518245", "BibTeX": "@article{26518245, title={Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial.}, author={Forteza A and Evangelista A and Sánchez V and Teixidó-Turà G and Sanz P and Gutiérrez L and Gracia T and Centeno J and Rodríguez-Palomares J and Rufilanchas JJ and Cortina J and Ferreira-González I and García-Dorado D}, journal={Eur Heart J}, volume={37}, number={12}, pages={978-85}}"}}, {"_id": "9460590", "pmid": 9460590, "title": "[Effect of the long-term atenolol therapy on the structural and functional parameters of the left ventricle in patients with dilated cardiomyopathy].", "journal": "Eksp Klin Farmakol", "authors": ["Sisakian AS"], "date": "1997-11-01T00:00:00Z", "meta_date_publication": "1997 Nov-Dec", "meta_volume": "60", "meta_issue": "6", "meta_pages": "17-20", "score": 50064.79, "text_hl": "[Effect of the long-term @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ therapy on the structural and @DISEASE_Conversion_Disorder @DISEASE_MESH:D003291 @@@functional@@@ parameters of the left ventricle in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Cardiomyopathy_Dilated</m> @DISEASE_MESH:D002311 @@@dilated cardiomyopathy@@@].", "citations": {"NLM": "Sisakian AS. [Effect of the long-term atenolol therapy on the structural and functional parameters of the left ventricle in patients with dilated cardiomyopathy]. Eksp Klin Farmakol. 1997 Nov-Dec;60(6):17-20. PMID: 9460590", "BibTeX": "@article{9460590, title={[Effect of the long-term atenolol therapy on the structural and functional parameters of the left ventricle in patients with dilated cardiomyopathy].}, author={Sisakian AS}, journal={Eksp Klin Farmakol}, volume={60}, number={6}, pages={17-20}}"}}, {"_id": "7093084", "pmid": 7093084, "title": "Role of the Frank-Starling mechanism during maximal semisupine exercise after oral atenolol.", "journal": "Br Heart J", "authors": ["Andersen K", "Vik-Mo H"], "date": "1982-08-01T00:00:00Z", "doi": "10.1136/hrt.48.2.149", "meta_date_publication": "1982 Aug", "meta_volume": "48", "meta_issue": "2", "meta_pages": "149-55", "score": 50063.44, "text_hl": "We conclude that @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ changes the left ventricular response to maximal semisupine exercise in normal man, with @<m>DISEASE_Cardiomyopathy_Dilated</m> @DISEASE_MESH:D002311 @@@dilatation@@@ and a concomitant increase in systolic @DISEASE_Heart_defects_limb_shortening @DISEASE_MESH:C535850 @@@myocardial shortening@@@. ", "citations": {"NLM": "Andersen K, Vik-Mo H. Role of the Frank-Starling mechanism during maximal semisupine exercise after oral atenolol. Br Heart J. 1982 Aug;48(2):149-55. PMID: 7093084", "BibTeX": "@article{7093084, title={Role of the Frank-Starling mechanism during maximal semisupine exercise after oral atenolol.}, author={Andersen K and Vik-Mo H}, journal={Br Heart J}, volume={48}, number={2}, pages={149-55}}"}}, {"_id": "1680558", "pmid": 1680558, "title": "[Tolerance of beta blockader treatment in dilated cardiomyopathy].", "journal": "Cardiologia", "authors": ["Mattioli AV", "Bettelli G", "Mattioli G"], "date": "1991-03-01T00:00:00Z", "meta_date_publication": "1991 Mar", "meta_volume": "36", "meta_issue": "3", "meta_pages": "223-7", "score": 50062.96, "text_hl": "[Tolerance of beta blockader treatment in @<m>DISEASE_Cardiomyopathy_Dilated</m> @DISEASE_MESH:D002311 @@@dilated cardiomyopathy@@@].", "citations": {"NLM": "Mattioli AV, Bettelli G, Mattioli G. [Tolerance of beta blockader treatment in dilated cardiomyopathy]. Cardiologia. 1991 Mar;36(3):223-7. PMID: 1680558", "BibTeX": "@article{1680558, title={[Tolerance of beta blockader treatment in dilated cardiomyopathy].}, author={Mattioli AV and Bettelli G and Mattioli G}, journal={Cardiologia}, volume={36}, number={3}, pages={223-7}}"}}]}